Zobrazeno 1 - 10
of 15 696
pro vyhledávání: '"John A"'
Autor:
Charles L, Vogel, Melody A, Cobleigh, Debu, Tripathy, John C, Gutheil, Lyndsay N, Harris, Louis, Fehrenbacher, Dennis J, Slamon, Maureen, Murphy, William F, Novotny, Michael, Burchmore, Steven, Shak, Stanford J, Stewart, Michael, Press
Publikováno v:
Journal of Clinical Oncology. 41:1638-1645
PURPOSE To evaluate the efficacy and safety of first-line, single-agent trastuzumab in women with HER2-overexpressing metastatic breast cancer. PATIENTS AND METHODS One hundred fourteen women with HER2-overexpressing metastatic breast cancer were ran
Autor:
Naif Fnais, Francisco Laxague, Faisal Alzahrani, Kevin Fung, Eric Di Gravio, Danielle MacNeil, Adrian Mendez, John Yoo, Pencilla Lang, Joe S. Mymryk, John W. Barrett, Keng Yow Tay, Andrew Leung, Anthony C. Nichols, David A. Palma
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:521-529
Primary radiation therapy with or without chemotherapy (RT/CRT) is the most common treatment for oropharyngeal squamous cell carcinomas (OPSCC), but there has been an increase in transoral surgery (TOS) for T1-2 tumors. Because only a subset of T1-2
Autor:
Kreepa G Kooblall, Victoria J Stokes, Omair A Shariq, Katherine A English, Mark Stevenson, John Broxholme, Benjamin Wright, Helen E Lockstone, David Buck, Simona Grozinsky-Glasberg, Christopher J Yates, Rajesh V Thakker, Kate E Lines
Publikováno v:
Endocrine-Related Cancer. 29:557-568
Multiple endocrine neoplasia type 1 (MEN1), caused by mutations in the MEN1 gene encoding menin, is an autosomal dominant disorder characterised by the combined occurrence of parathyroid, pituitary and pancreatic neuroendocrine tumours (NETs). Develo
Autor:
Ryan J. Stubbins, Ryan Lam, James Zhu, Sunita Ghosh, Curtis Mabilangan, John Kuruvilla, Rashmi S Goswami, Raymond Lai, Jutta K Preiksaitis, Michael D Jain, Anthea C Peters
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:744-752
The tumor microenvironment (TME) in post-transplant lymphoproliferative disorders (PTLDs) remains unexplored. Tumor infiltrating lymphocytes (TILs) are prognostic in other lymphomas. We assessed the prognostic impact of TILs in monomorphic B-cell PTL
Autor:
Omali Pitiyarachchi, Michael Friedlander, James J. Java, John K. Chan, Deborah K. Armstrong, Maurie Markman, Thomas J. Herzog, Bradley J. Monk, Floor Backes, Angeles Alvarez Secord, Albert Bonebrake, Peter G. Rose, Krishnansu S. Tewari, Samuel S. Lentz, Melissa A. Geller, Larry J. Copeland, Robert S. Mannel
Publikováno v:
Gynecologic Oncology. 166:410-416
Patients with advanced epithelial ovarian cancer (EOC) alive without progression at a landmark time-point of 10 years from diagnosis are likely cured. We report the proportion of patients with Stage III EOC who were long-term disease-free survivors (
Autor:
Subhadip Das, Salman Faruqi, Robert Nordal, Yves Starreveld, John Kelly, Gregory Bowden, John Amanie, Alysa Fairchild, Gerald Lim, Shaun Loewen, Lindsay Rowe, Carla Wallace, Sunita Ghosh, Samir Patel
Publikováno v:
BMC Cancer. 22
Background Postoperative stereotactic radiosurgery (SRS) is a standard management option for patients with resected brain metastases. Preoperative SRS may have certain advantages compared to postoperative SRS, including less uncertainty in delineatio
Autor:
Alain Tremblay, Christian Couture, John R. Goffin, Paul MacEachern, Zhaolin Xu, Annette McWilliams, Dean A. Regier, Garth Nicholas, Kayvan Amjadi, Frances A. Shepherd, William K. Evans, Paul Burrowes, Ian Cromwell, Jean M. Seely, Glenwood D. Goss, Michael R. Johnston, Rick Bhatia, John Yee, Martin C. Tammemägi, Richard J. Finley, Serge Puksa, Heidi C. Roberts, Ming-Sound Tsao, John R. Mayo, Sonya Cressman, Stephen Lam, Simon Martel, Natasha B. Leighl, Corneliu Bolbocean, Kazuhiro Yasufuku, Stefan J. Urbanski, S. Atkar-Khattra, Harmanjatinder S. Sekhon, Diana N. Ionescu, Stuart Peacock, Daria Manos, Geoffrey Liu, Wan C. Tan, Don D. Sin, Kamyar Soghrati, John C. English, David M. Hwang, Jean-Claude Cutz
Publikováno v:
Journal of Thoracic Oncology
Background It is estimated that millions of North Americans would qualify for lung cancer screening and that billions of dollars of national health expenditures would be required to support population-based computed tomography lung cancer screening p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b529ba04cc888b464bdfc93d33eddb9
https://doi.org/10.1097/jto.0000000000000283
https://doi.org/10.1097/jto.0000000000000283
Autor:
Ariadna Juarez-Garcia, John C O'Donnell, John R. Penrod, Mats Rosenlund, Simon Ekman, Jens Benn Sørensen, Anne Mette Kejs, Pia Horvat, L. Lacoin, Odd Terje Brustugun, Dony Patel, M. Daumont
Publikováno v:
Sørensen, J B, Horvat, P, Rosenlund, M, Kejs, A M, Patel, D, Juarez-Garcia, A, Lacoin, L, Daumont, M J, Penrod, J R, O'donnell, J C, Brustugun, O T & Ekman, S 2022, ' Initial treatment and survival in Danish patients diagnosed with non-small-cell lung cancer (2005-2015) : SCAN-LEAF study ', Future Oncology, vol. 18, no. 2, pp. 205-214 . https://doi.org/10.2217/fon-2021-0746
Aim: To describe initial treatment patterns and survival of patients diagnosed with non-small-cell lung cancer (NSCLC) in Denmark, before immune checkpoint inhibitor and later-generation tyrosine kinase inhibitor use. Patients & methods: Adults diagn
Autor:
Martin C Tammemägi, Mamta Ruparel, Alain Tremblay, Renelle Myers, John Mayo, John Yee, Sukhinder Atkar-Khattra, Ren Yuan, Sonya Cressman, John English, Eric Bedard, Paul MacEachern, Paul Burrowes, Samantha L Quaife, Henry Marshall, Ian Yang, Rayleen Bowman, Linda Passmore, Annette McWilliams, Fraser Brims, Kuan Pin Lim, Lin Mo, Stephen Melsom, Bann Saffar, Mark Teh, Ramon Sheehan, Yijin Kuok, Renee Manser, Louis Irving, Daniel Steinfort, Mark McCusker, Diane Pascoe, Paul Fogarty, Emily Stone, David C L Lam, Ming-Yen Ng, Varut Vardhanabhuti, Christine D Berg, Rayjean J Hung, Samuel M Janes, Kwun Fong, Stephen Lam
Publikováno v:
The Lancet. Oncology
Summary Background Lung cancer is a major health problem. CT lung screening can reduce lung cancer mortality through early diagnosis by at least 20%. Screening high-risk individuals is most effective. Retrospective analyses suggest that identifying i
Autor:
Sung Won Choi, John Maciejewski, John M. Magenau, Mary Riwes, Attaphol Pawarode, Gregory A. Yanik, Thomas Braun, Daniel Peltier, Moshe Talpaz, Monalisa Ghosh, Brian Parkin, Sarah Anand, Pavan Reddy
Publikováno v:
Blood Advances. 5:5047-5056
A potent graft-versus-leukemia (GVL) response is crucial in preventing relapse, the major impediment to successful allogeneic hematopoietic cell transplantation (HCT). In preclinical studies, type 1 interferon (IFN-α) enhanced cross-presentation of